|
Friday, November 18, 2016
Print Current Session:
 |
|
|
Friday
SESSION 75:
MORE CAROTID DISEASE AND TREATMENT RELATED TOPICS AND CONTROVERSIES; TRANSCERVICAL CAS (TCAR) AND NEW MESH COVERED CAROTID STENTS
Moderators:Klaus D. Mathias, MD / Claudio J. Schonholz, MD
|
|
| SESSION 75 SCHEDULE | |
| 1:00 PM - 1:05 PM | Midterm Results Of The ROADSTER PIVOTAL Trial Of The Silk Road System For TransCarotid Artery Stent Revascularization (TCAR) In High Risk Patients With Carotid Stenosis |
| Presenter(s):Mahmoud B. Malas, MD, MHS / Christopher J. Kwolek, MD / Richard P. Cambria, MD | |
| View Slides in PDF | |
| 1:06 PM - 1:11 PM | New Developments In The Silk Road System For TCAR: Details And Improvements In The Enroute System For CAS: How It Works And Achieves Flow Reversal Embolic Protection: Indications, Contraindications And Learning Curve Issues |
| Presenter(s):Christopher J. Kwolek, MD / Richard P. Cambria, MD | |
| View Slides in PDF | |
| 1:12 PM - 1:17 PM | Early Results Of The ROADSTER 2 Post-Market Registry Of TCAR In Normal Risk And High Risk Patients With Carotid Stenosis |
| Presenter(s):Vikram S. Kashyap, MD / Peter A. Schneider, MD | |
| View Slides in PDF | |
| MEGA DEBATE ON TIMING AFTER SYMPTOM ONSET | |
| 1:18 PM - 1:23 PM | DEBATE: Early CEA After Symptom Onset Is Beneficial To Patients: The Earlier The Better After Certain Requirements Are Met |
| Presenter(s):Ross Naylor, MD, FRCS | |
| View Slides in PDF | |
| 1:24 PM - 1:29 PM | DEBATE: Early CEA After Symptoms (TIA Or Small Stroke): Timing Is Everything: Within 48 Hours Is Bad: Within 3-14 Days Is Good: Why |
| Presenter(s):Ian Loftus, MD | |
| View Slides in PDF | |
| 1:30 PM - 1:35 PM | DEBATE: Early CEA (Within 48 Hours) After TIA Or Stroke: A Balanced View: What Are The Risks And Benefits: Early Brain Imaging And Carotid Duplex Can Help Select Patients For Safe, Early Intervention |
| Presenter(s):Laura Capoccia, MD, PhD | |
| View Slides in PDF | |
| 1:36 PM - 1:41 PM | DEBATE: Another Balanced View: When Is Early CEA After Symptom Onset In Patients With Carotid Stenosis Safe And Beneficial And When Is It Not |
| Presenter(s):Martin Bjorck, MD, PhD | |
| View Slides in PDF | |
| NEW MESH COVERED CAROTID STENTS | |
| 1:42 PM - 1:47 PM | Comparison Of 3 Micromesh Covered Stents For CAS: Indications For Each And > 1-Year Clinical Results |
| Presenter(s):Piotr Musialek, MD, DPhil / Max Amor, MD | |
| View Slides in PDF | |
| 1:48 PM - 1:53 PM | Impact Of TCAR And Micro-Mesh Stent Usage With The C-Guard Stent (Inspire MD) On CAS: Do They Decrease DW MRI Cerebral Embolic Lesions: Which Helps Most |
| Presenter(s):Piotr Musialek, MD, DPhil / Mariusz Trystula, MD, PhD | |
| View Slides in PDF | |
| 1:54 PM - 1:59 PM | Dual Layer Micromesh Stents Decrease New Ischemic Brain Lesions After CAS: What Is The Functional Significance And Will These Micromesh Stents Have Downsides |
| Presenter(s):Maria Antonella Ruffino, MD, EBIR | |
| View Slides in PDF | |
| 2:00 PM - 2:06 PM | Panel Discussion |
| END OF SESSION 75 | |
| previous | next |